Aclaris Therapeutics Inc’s recent filing unveils that its Director Powell Andrew Kenneth William acquired Company’s shares for reported $7500.0 on
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Aclaris Therapeutics
Aclaris Therapeutics Inc’s recently made public that its Director Powell Andrew Kenneth William acquired Company’s shares for reported $7500.0 on
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Aclaris Therapeutics Inc’s filing revealed that its Director Powell Andrew Kenneth William acquired Company’s shares for reported $7500.0 on Mar
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Aclaris Therapeutics Inc’s filing revealed that its Director Powell Andrew Kenneth William acquired Company’s shares for reported $7500.0 on Mar